Get a structured handoverArafat Mulla, specialty trainee year 4 in respiratory medicine, North West deanery, says, “Be in […]
Author: Clinical Editor
Are cloth masks still recommended?Early in the pandemic, major problems in the global supply of medical grade masks […]
Accelerate@Babraham supports early-stage life sciences ventures within the Babraham Research Campus’ community
CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial
CDK4 & 6 inhibitor has been available as part of a Cancer Drugs Fund (CDF) managed access agreement
People aged 65 to 69 and the clinically vulnerable will be offered the jab from today
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer […]
A new research paper reveals a potential revolutionary drug combination that could become an effective treatment for the […]
Ebola is so pernicious because it pulls a fast one on the body, disguising itself as a dying […]
ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data chelfand Sat, 02/13/2021 […]